SCHEDULE: Renaissance Technologies Discloses 5.19% Stake in USANA Health Sciences

Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have reported a beneficial ownership of 5.19% in USANA Health Sciences Inc., holding 958,520 shares.

Summary

• Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have filed a Schedule 13G, indicating their beneficial ownership of USANA Health Sciences Inc. common stock.
• The total number of shares beneficially owned is 958,520, representing 5.19% of the class of securities.
• Both entities, RTC and RTHC, are organized in Delaware.
• The filing confirms sole voting and sole dispositive power for the reported shares.
• The reporting date for this event is June 30, 2026, with the amendment filed on August 13, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, reflecting a significant but not dominant ownership stake by a major investment firm. The disclosure itself is routine for Schedule 13G filings.

Positives

• Significant investment by a well-known quantitative investment firm, Renaissance Technologies, suggests confidence in USANA Health Sciences' long-term prospects.
• The filing clearly states sole voting and dispositive power, indicating direct control over the investment decisions for these shares.

Negatives

• The filing does not provide specific financial performance data for USANA Health Sciences, only ownership details.

Risks

• As a Schedule 13G filing, it primarily reports ownership and does not detail specific operational risks of USANA Health Sciences.
• The investment firm's strategy may involve active trading, leading to potential share price volatility if they decide to adjust their holdings.

Future Outlook

This filing is a disclosure of ownership and does not contain forward-looking statements or guidance regarding USANA Health Sciences' future performance.

Management Comments

• Brian Felczak, Chief Financial Officer of Renaissance Technologies LLC, certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Industry Context

StockSavvy.ai notes that significant institutional ownership, as reported in this Schedule 13G, is common in the health sciences and direct selling industries. Renaissance Technologies' involvement indicates a quantitative approach to identifying investment opportunities within this sector.

Stakeholder Impact

• Shareholders: May view the increased institutional ownership positively, potentially leading to greater liquidity and market interest.
• Management of USANA Health Sciences: Will be aware of a significant institutional investor's stake, which could influence strategic decisions or board composition discussions.

Next Steps

• Continued monitoring of Renaissance Technologies' holdings in USANA Health Sciences for any changes in ownership percentage or voting power.
• Review of future USANA Health Sciences filings for operational and financial updates.

Key Dates

Keywords

USANA Health Sciences, Renaissance Technologies, Schedule 13G, Beneficial Ownership, Investment, Common Stock, Securities